Neumora Therapeutics Inc.... (NMRA)

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

undefined

undefined%

At close: undefined

10.32

0.29%

After-hours Dec 13, 2024, 04:39 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.

Boring Mode

Year	FY23	FY22	FY21	FY20
Revenue	-	-	-	-
Cost of Revenue	668.00K	2.70M	1.55M	-
Gross Profit	-668.00K	-2.70M	-1.55M	-
Operating Income	-188.19M	-135.87M	-237.32M	-95.52M
Interest Income	16.61M	4.56M	-	-
Pretax Income	-235.66M	-130.90M	-237.31M	-99.27M
Net Income	-235.93M	-130.90M	-237.31M	-99.27M
Selling & General & Admin	44.81M	31.12M	24.55M	8.39M
Research & Development	142.72M	104.75M	212.78M	87.13M
Other Expenses	-	405.00K	11.00K	-3.75M
Operating Expenses	187.53M	135.87M	237.32M	95.52M
Interest Expense	-	-	-	-
Selling & Marketing Expenses	-668.00K	-	-	-
Cost & Expenses	188.19M	135.87M	237.32M	95.52M
Income Tax	268.00K	-4.56M	301.44K	-101.30K
Shares Outstanding (Basic)	158.83M	151.95M	151.95M	151.95M
Shares Outstanding (Diluted)	158.83M	151.95M	151.95M	151.95M
EPS (Basic)	-1.49	-0.86	-1.56	-0.65
EPS (Diluted)	-1.49	-0.86	-1.56	-0.65
EBITDA	-187.53M	-135.28M	-236.78M	-95.41M
Depreciation & Amortization	668.00K	2.70M	1.55M	105.00K